Clinical Trials Insight: 700029929
Phase of Trial: Phase I
Latest Information Update: 03 Mar 2011
At a glance
- Drugs Davunetide (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Allon Therapeutics
- 03 Mar 2011 Results presented at the American Society for Clinical Pharmacology and Therapeutics in March 2011, according to an Allon Therapeutic media release.
- 12 Aug 2008 Status changed from recruiting to completed according to Allon Therapeutics media release.
- 12 Aug 2008 Results reported in Allon Therapeutics media release.